The Pilot Phase of the NIH Chemical Genomics Center
- 1 September 2009
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 9 (13) , 1181-1193
- https://doi.org/10.2174/156802609789753644
Abstract
Abstract: The NIH Chemical Genomics Center (NCGC) was the inaugural center of the Molecular Libraries and Screening Center Network (MLSCN). Along with the nine other research centers of the MLSCN, the NCGC was established with a primary goal of bringing industrial technology and experience to empower the scientific community with small molecule compounds for use in their research. We intend this review to serve as 1) an introduction to the NCGC standard operating procedures, 2) an overview of several of the lessons learned during the pilot phase and 3) a review of several of the innovative discoveries reported during the pilot phase of the MLSCN.Keywords
This publication has 43 references indexed in Scilit:
- A Specific Mechanism for Nonspecific Activation in Reporter-Gene AssaysACS Chemical Biology, 2008
- A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarkerToxicology in Vitro, 2008
- Compound Management for Quantitative High-Throughput ScreeningSLAS Technology, 2008
- Identification of oxadiazoles as new drug leads for the control of schistosomiasisNature Medicine, 2008
- Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-LactamaseJournal of Medicinal Chemistry, 2008
- Characterization of Diversity in Toxicity Mechanism Using in Vitro Cytotoxicity Assays in Quantitative High Throughput ScreeningChemical Research in Toxicology, 2008
- Identification of a potent new chemotype for the selective inhibition of PDE4Bioorganic & Medicinal Chemistry Letters, 2008
- N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher diseaseBioorganic & Medicinal Chemistry Letters, 2007
- Mechanism of action of novel NO‐releasing furoxan derivatives of aspirin in human plateletsBritish Journal of Pharmacology, 2006
- Evaluation of Small-Molecule Modulators of the Luteinizing Hormone/Choriogonadotropin and Thyroid Stimulating Hormone Receptors: Structure−Activity Relationships and Selective Binding PatternsJournal of Medicinal Chemistry, 2006